Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic EffectsYa‐Wen Cheng, Shiou-Hwei Yeh, Ya‐Min Tsai et al.|Cell Reports|2020Cited by 277
Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal modelsHan-Yi Huang, Chi‐Huey Wong, Hsin-Yu Liao et al.|Science Translational Medicine|2022Cited by 127
A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variantPan‐Chyr Yang, Chi‐Fan Yang, Yi‐Fen Chen et al.|EMBO Molecular Medicine|2022Cited by 66
Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infectionKuo‐Yen Huang, Pan‐Chyr Yang, M. L. Lin et al.|EMBO Molecular Medicine|2020Cited by 64
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike CleavageYa‐Wen Cheng, Shiou‐Hwei Yeh, Tai‐Ling Chao et al.|mBio|2021Cited by 49